Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Diabetes Now Fuels Rising Chronic Kidney Disease Despite New TreatmentsLongevity & Aging

Diabetes Now Fuels Rising Chronic Kidney Disease Despite New Treatments

Chronic kidney disease affects roughly 36 million U.S. adults and its overall prevalence has barely budged over the past decade, hovering near 14.8%. But underneath that stable surface, a troubling shift is happening: kidney disease caused by diabetes increased from 4.7% to 5.7% between 2013 and 2023, even as newer kidney-protective drugs like SGLT2 inhibitors became widely available. Heart failure is also strongly linked to CKD, and researchers warn that kidney disease increasingly travels alongside heart and metabolic conditions. Critically, 87% of adults with CKD don't know they have it, making early screening — especially albuminuria testing — a key priority for anyone with diabetes, high blood pressure, or heart disease.

0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.